Activated JNK induces Ser 307 phosphorylation of insulin receptor substrate-1 (IRS-1), which alters insulin downstream signaling, and subsequently causes systemic insulin resistance, metabolic syndrome, and T2D [4,44,45]. Here, IRS1 is linked to metabolic syndrome.